CLINICAL_TRIALS
trial_result
· 2014-05-20
Clinical Trial Update: Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate Cancer [Phase 2]
Summary
Phase II trial evaluating metronomic dosing of etoposide and cyclophosphamide in prostate cancer has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rutgers, The State University of New Jersey | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-05-20